biote Corp.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$108M
↓-12.1% -$15Mvs FY2024
Total Liabilities
$158M
↓-29.6% -$67Mvs FY2024
Cash
$24M
↓-38.7% -$15Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $108M | $122M |
| Current Assets | $55M | $68M |
| Cash | $24M | $39M |
| ST Investments | $0 | $0 |
| Receivables | $7M | $8M |
| Inventory | $19M | $15M |
| Other Current | $5M | $6M |
| Non-Current Assets | $53M | $54M |
| PPE | $11M | $7M |
| Goodwill | $6M | $6M |
| Intangibles | $4M | $6M |
| Investments | $0 | $0 |
| Other Non-Current | $32M | $36M |
| Total Liab+Eq | $99M | $119M |
| Current Liab. | $45M | $52M |
| Accounts Payable | $7M | $6M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $3M | $3M |
| Other CL | $35M | $43M |
| Non-Current Liab. | $113M | $173M |
| Long-Term Debt | $103M | $101M |
| Other LT Liab. | $10M | $72M |
| Equity | $-59M | $-106M |
| Retained Earnings | $50M | $100M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · BTMD · Comparing FY2025 vs FY2024